Press Releases

NEW HAVEN, Conn., Dec. 17, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced positive topline results from its randomized, dose ranging, placebo controlled, pivotal Phase 2/3 clinical trial (BHV3500-201; NCT03872453) evaluating the efficacy and tolerability of intranasal vazegepant 5, 10 and 20 mg versus placebo in 1,673

BOSTON, Dec. 17, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced positive topline results from the Company's global, multicenter, randomized, placebo-controlled, 28-day, Phase 2 study eva

DRAPER, Utah, Dec. 17, 2019 /PRNewswire/ -- 1-800 Contacts, the leading online contact lens retailer announced today that it entered into a definitive written agreement to acquire

LAVAL, Quebec, Dec. 17, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has launched an offering of a combined $1,250,000,000 aggregate principal amount of new senior notes due 2028 (the "2028 Notes") and new senior notes due 2030 (the "2030 Notes" and, togethe

MASON, Ohio, Dec. 17, 2019 /PRNewswire/ -- Prasco announced today the launch of the authorized generic of NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring). This is Prasco's 9th authorized generic launch in partnership with Merck & Co., Inc., and the 9th women's health product Prasco has brought to market. Etonogestrel/Ethinyl Estradiol Vaginal Ring is a sm

LUND, Sweden, Dec. 17, 2019 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced that the first patient has been successfully dosed in the Phase I study with the wholly owned 4-1BB antibody ATOR-1017, which is being developed for the treatment of metastasized cancer.The Phase I study is a dose escalation study in patients w

BLOOMFIELD, Conn., Dec. 17, 2019 /PRNewswire/ -- With mental health issues on the rise in America, Cigna is making it simpler and more convenient for its customers to seek care for conditions like anxiety, stress, and depression. Beginning in January 2020, Cigna's 14 million customers enrolled in employer-sponsored plans can schedule appoint

SPRINGDALE, Ark., Dec. 17, 2019 /PRNewswire/ -- Therapon Skin Health, the makers of the medical grade skincare line Theraderm® Clinical Skin Care,

CHICAGO, Dec. 17, 2019 /PRNewswire/ -- The Blue Cross Blue Shield Association (BCBSA) and Blue Health Intelligence® (BHI®) announced today that Thrive Earlier Detection (Thrive) has won the BlueCross BlueShield Data Innovation Challenge. Out of more than 130 submissions and five finalists, Thrive was chosen for its proposal

KATY, Texas, Dec. 17, 2019 /PRNewswire/ -- Athlete Training and Health proudly celebrates recent achievements by Micheál Cahill, vice president, performance and sports science. Cahill has earned his PhD in sport and exercise science from New Zealand's Auckland University of Technology, an ATH partner that also aims to bring th